Agenus Inc (AGEN)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Garo H. Armen
Employees:
440
3 FORBES ROAD, LEXINGTON, MA, 02421
781-674-4410
-
Formally known as:
- Antigenics Inc.
Date | Ratio |
---|---|
2011-10-03 | 1:6 |
2023-04-26 | 1019:1000 |
Agenus Inc. discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It also develops Balstilimab, an anti-PD-1 antagonist that has completed Phase II clinical trial to treat second line cervical cancer.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|